Syphilis as a Field for Research by the Dermatologist11Presidential Address, Read before the Eighth Annual Meeting of the Society for Investigative Dermatology, Atlantic City, N.J., June 10, 1947.  by Beerman, Herman
SYPHILIS AS A FIELD FOR RESEARCH
BY THE DERMATOLOGIST'
HERMAN BEERMAN, M.D.2
The trend of modern practice is toward the separation of syphilology from
dermatology and the abolition of syphilology as a specialty. Although this ten-
dency was initiated long ago, it has recently received added impetus because of
the advent of penicillin therapy. It is contended that since this mode of treat-
ment is so safe and effective, the fine points of diagnosis and differentiation of
syphilis from other dermatoses may be dispensed with, and that no real harm will
come from the wholesale, almost indiscriminate, use of the drug. Furthermore,
the exigencies of war have indicated that research in syphilis is no longer a matter
of individual endeavor but can best be carried out as a group effort by so-called
syphilologists as well as by workers in various medical fields, especially internal
medicine. Not only has research in syphilis been removed from the sphere of
the specialist in syphilology but the actual management of the disease is said
to have become entirely the province of the Public Health agencies and to be no
longer of interest to the dermato-syphilologist, either scientifically or econom-
ically. Future research in syphilis, therefore, is said to lean to\vard epidemio-
logy rather than to the study of the biology of the disease. In addition to
these recent developments, certain dermatologists feel that there is no excuse
for the existence of syphilology as a specialty or partner of dermatology since
the base upon which the alliance rests (the cutaneous manifestations of syphilis)
is too superficial for permanency. Although much advance has been made in
syphilology, the opponents of the continued alliance quote no less an authority
than Fielding Garrison (1) to prove that the basic advances in this field were not
made by syphilologists: "The first steps in the conquest of syphilis had thus
been made by professional zoologists, Metchnikoff and Schaudinn. The next
advances were made by an investigator (Ehrlich) who, although educated as a
physician, really worked out his results as a chemist and pharmacologist."
I do not intend to review the polemic aspects of this controversy, nor do I plan
to do more than remind you of the long linkage between dermatology and
syphilology (recently further cemented by the military organization). I wish
to reemphasize to you as dermatologists the possibilities offered by syphilis as a
field for research and the necessity for us to assume responsibility for this disease,
even though eventually the combination of dermatology and syphilology may
break up. I do this because syphilis is a major interest of the Society for Inves-
tigative Dermatology, in accordance with its constitution, and the meeting of a
society fostering research is an appropriate place to evaluate the possibilities in
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this field. Furthermore, I have spent most of my professional life in syphilis
research of various types, and although I concede the great opportunities of
dermatologic research, I believe there are scientific possibilities for the dermato-
syphilologist in the study of the problems of syphilis as a disease process. Ac-
cordingly, I propose to review briefly some aspects of the syphilis problem, fur-
ther study of which might add to our store of knowledge of this disease as a sys-
temic versus local process, and to indicate that this further study is the legitimate
province of the dermatologist.
Syphilology is no different from any other field of medicine. All groups must
lean on each other and it is not to the discredit of syphilologists that many fun-
damental discoveries useful to the progress of syphilology were made by other
than syphilologists. This practice is apparently general, since Goodpasture (2)
in his lecture on Research and Medical Practice stated: "Increasing knowledge
of chemistry, physics, physiology, pathology and bacteriology has further limited
the physician's authority, for now he must resort to expert advice from the
laboratory for the fundamental knowledge necessary for diagnosis, prognosis,
and even treatment. Electrocardiography, X-ray, chemical, bacteriological and
serological tests and the microscopic examination of tissues and specimens have
become such technical procedures and are so necessary to modern medicine that
the practitioner cannot do without them and must rely upon the reports of
specialists in those subjects."
DIFFICULTIES OF RESEARCH IN SYPHILIS
I have the impression, based on observation and discussion with others, that
once the inertia of the dermatologist toward syphilis research is overcome, he still
would find it hard to engage in this work because of certain factors. Fundamen-
tal research in syphilis, utilizing animals and a chronic infection which may at
times be asymptomatic, involves much time, an expensive set-up, and a return
in experimental results which may be small. For example, my active interest in
treatment resistance in syphilis dates back to about 1932 when an opportunity
arose to study this problem experimentally in rabbits. After nine and one-half
years, the fruits of our work, supported by a private organization, culminated in
a report in our Journal (3) in which it was stated that Spirochaeta pallida derived
from a treatment-refractory patient may retain a certain amount of this charac-
teristic resistance to treatment when the strain had been carried through numer-
ous animal passages. On the face of it, a small return for so much energy, time
and money when compared with the ten or more small dermatologic problems I
could have tackled in those years and could have reported on prolifically. I will
concede that while research in dermatology may yield all the benefits of syphilo-
logic research to the individual, research in syphilis by the nature of the disease
teaches one to have infinite patience and critical consideration. Modern ad-
vances in the mode of syphilis research involving group activities (panels, whole-
sale expenditure and pooling of personnel, money and facilities) may yield an
entirely different perspective from that gained by leisurely personal, individual
or small-group attack on a problem. Accordingly, in spite of its drawbacks of
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time consumption, cost and relative lack of facilities, research in the fundamental
fundamental problems of syphilis offers as interesting and fruitful a field for the
dermatologist as some of the more fascinating phtses of dermatologic research.
On the other hand, syphilis, always a constitutional disease, affords a wide scope
of possibilities for the study of a general versus a local process. It also yields,
because of the difficulties inherent in syphilis, research, a challenge to the inge-
nuity of the dermatologist.
SOME CONTRIBUTIONS BY DERMATOLOGISTS TO SYPHILIS IN THE PAST
Dermatologists, contrary to the expressed opinions of those wishing to separate
syphilology from our field, have made substantial contributions to syphilology.
I need only mention several. L. Duncan Bulkley (4) the person most responsible
for the existence of the New York Skin and Cancer Hospital, graduate of the
College of Physicians and Surgeons in 1869, student in dermatology at the Hos-
pital Saint Louis, and one of the founders of the American Dermatological Asso-
ciation, won the Alvarenga prize in 1891 from the College of Physicians of Phila-
delphia with his monograph, "Syphilis of the Innocent." The first Journal on
dermatology in America, which appeared in 1870, was entitled, "The American
Journal of Syphilology and Dermatology." Prince A. Morrow (5) who contrib-
uted extensively to both dermatology and syphilology, and whose three volumes,
A System of Genito-Urinary Diseases," (1892—94) still make interesting and
valuable reading, was so inspired by an interest in the prophylaxis of syphilis
that he later practically made it his life's work. Numerous similar examples of
research in syphilis by the dermatologist can be mentioned down to the present.
For instance, one of the most outstanding of the recent contributions of dermatol-
ogists to syphilis research is that of the Cooperative Clinical Group headed by
Cole, O'Leary, Moore, Stokes and Wile. Continuation of this type of endeavor
by us is to maintain a worthy precedent.
Research in syphilis even holds rewards for the syphilologist's old age. It is
certain that the historical features of the glorious or infamous past of this disease
will not be worked out in our lifetime. The battle over the American versus the
Old World origin of syphilis, and many similar problems, will still afford happy
hunting for the declining years of many an "old syphilologist" researcher.
FUNDS AND OPPORTUNITIES FOR RESEARCH IN SYPHILIS
The dermatologist cannot use lack of funds or facilities as an excuse for avoid-
ing syphilis research. Various opportunities, both financial and physical, are
available to the dermatologist seeking to engage in syphilis research. Private
sources, as well as public funds, are available to eligible persons. Pharmaceutical
houses are always ready to support fundamental studies in syphilology. For
fifteen years under a contract designed for this purpose, described by Stokes and
Beerman (1937) (6) we have studied a variety of problems in this field. The work
was supported entirely by a grant from a pharmaceutical house but the policy and
type of work done were under the aegis of a great University. On the other
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hand, the United States Public Health Service (7) fosters fundamental syphilis
research in addition to epidemiology. It has, in fact, a mechanism for making
funds available, through the Research Grant Division of the National Institute
of Health, to individuals as well as organizations such as hospitals, universities
or laboratores, for long or short-term projects. This support does not in any
way imply Federal control, supervision or direction of the project.
Remarkable developments in syphilology apparently occur in cycles and there
are periods in \vhich one feels confident that the ultimate has been attained. Thus
in the penicillin era we have the impression that we have reached the final goal.
In fact, we are merely echoing what Ncisser (8) had to say about syphilology in
1911: "European physicians have known syphilis for more than four centuries,
and for almost as long scientific medicine has been using mercury in its treatment.
Yet only the last eight years have improved our knowledge of the nature and
pathology of the disease sufficiently, so that we are able to replace a purely em-
pirical and, therefore, uncertain treatment with a rational therapy: a therapy, the
principles of which are based not merely upon hypotheses and theoretical specu-
lations, but on actual observations. Seldom indeed has there been such notable
progress in any branch of medicine in such a short time as we now note in syphi-
lology. Best of all, these discoveries have been applied directly to the cure of
the patient, the highest goal of any medical research. It is important and grati-
fying that these extraordinary achievements, with all their still-unexplained and
unforeseen potentialities, have been attained neither by chance nor by crude
empiricism. On the contrary, modern syphilothcrapy is the result of exhaustive
research in the spheres of etiology, diagnosis and experimental pathology and
therapy."
All that remains to demonstrate that syphilology is not a closed book is to
recall the state of our knowledge of a few of the problems in this branch of medi-
cine. To begin with, much uncertainty still exists as to the nature of syphilis
itself, whether it is a group of syndromes or a single entity distinct from such
processes as yaws, pinta, bejel, etc. (9). Without proposing to take a partisan
viewpoint and side either with the unitarians or dualists, for orientation a general
definition of the whole group of treponcmatoses is given by the unitarian, Hud-
son (10) as follows: "Trcponematosis is a universally distributed acute and
chronic specific infectious disease, known in various times and places by many
names, such as syphilis, yaws, pinta, huhas, button scurvy, morbus gallicus,
bejcl, morfca, pian, irkintja, franghi, mentagra, carate, frainbcsia, venereal
leprosy, sibbens, empeines and redesyge. Caused by a treponema and propa-
gated both venereally and non-venereally, it is susceptible to treatment with the
heavy metals, is diagnosed by special tests, is characterized by an early and late
stage separated by a latent period, and evokes a characteristic pathological re-
sponse from human tissues." This definition summarizes the variety of aspects
of syphilis many of which still need much investigation. Little more is known
today than was known forty years ago about the biology of Spirochacta pallida,
the pathogenesis of syphilis, the mechanism of the serologic tests and the mode
of action of the antisyphilitic agents.
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FACTORS INFLUENCING THE COURSE OF SYPHILIS
In 1944 (11) we made a list of the factors said to affect the course of syphilis.
These include:
1. The Organism: Strain; rate of reproduction, route of inoculation; size of
inoculum.
2. Season: Sunlight.
3. Endocrine Hormones and Activity.
4. Diet.
5. Avitaminosis.
6. Defense I1/Ieehanivm. Skin and Bone Involvement. Reticulo-Endothelial
System.
7. Age.
8. Race: There are scattered data but no definitive experimental study on
this point.
9. Sex: Cause of milder course in women is still unknown.
10. Pregnancy: Numerous studies on the influence of pregnancy in syphilis
are summarized by the aphorism: "Pregnancy is good for syphilis but syphilis
is not good for pregnancy."
11. Intercurrent Infection: Scattered reports but our ignorance is still cloaked
with phrases such as "biotropism," etc.
12. II eat. Fever: Probable thermal death-point has been determined but the
mode of action of fever therapy is still a matter of conjecture.
13. Physical Strain.
14. Nervous and Mental Activity.
15. Physical Constitution.
16. Trauma.
17. Treatment.
None of these factors is clearly evaluated. Each of them supplies unlimited
sources of material for productive investigation.
THE ORGANI5M
Specifically, with regard to Spirochaeta pallida, some of the perplexing prob-
lems include the question of cultivation of a virulent organism, life cycle, strains
and interrelation among spirochetes.
Cultivation of Spirochaeta Pallida
Numerous attempts to cultivate virulent Spirochaeta pallida have been unsuc-
cessful at the hands of competent investigators [Gammel and Ecker (12); Kast.
and Kolmer (13) (14)] employing a variety of methods, including the chorio-
allantoic membrane of the chick embryo [Wile and Snow (15) (16) (17)]. The
recent recovery by Steinhaus and Hughes (18) of a spirochete from hen's eggs
after inoculation with liver tissue from hens, may invalidate this method com-
pletely. Solution of this problem would complete the requirements of the Laws
of Koch to establish Spirochaeta pallida as the cause of syphilis and it would
afford an unlimited source of virulent organisms for biologic and chemothera-
peutic studies.
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Life Cycle of Spirochaeta Pallida
The question of a life cycle and of evolution-forms of Spirochaeta pallida still
remain unanswered. Ingraham (19) (20) and later Olsen (21) have reviewed this
question thoroughly. The practical considerations which solution of this prob-
lem would yield are far-reaching, even to the mechanism of transmission of the
disease, since if Spirochaeta pallida is capable of changing into an ultramiscro-
seopic form and can conceal itself in a spermatozoon, paternal transmission of the
disease is a possibility which is now denied. Certain phases in the life cycle may
have an affinity for certain structures and thus remove the usually-employed
postulate of strains, viz., neurotropic and dermatropic, and even treatment-resist-
ant. Proof of the existence of a virus form may explain certain of the puzzles of
immunity in syphilis.
Strains of Spirochacta Pallida
The existence of strains of Spirochaeta pallida with distinctive biologic prop-
erties is still a highly debatable issue. Although the occurrence of neurotropic
and other strains is inferred from experimental and clinical evidence, definite
proof is lacking (22, 23). The concept of strains should have a significant bear-
ing in clinical syphilis but as yet this influence is little understood.
Interrelation Among Spirochetes
Little specific information is available about the interrelationship among
spirochetes. This is independent of strains as such although the differences are
more functional than morphologic. [Bessemans (24) (25)]. There is some evi-
dence that the organism causing yaws produce an infection which sometimes pro-
tects against syphihs. [Turner (26) (27)1. The organism causing hejel and that
producing pinta (9) may also be functional variations of Spiroehaeta pallida.
This is not yet demonstrated. The biologic relationship between the causative
agent of syphilis, yaws, and that causing venereal spirochetosis in rabbits which
is morphologically similar, has just begun to be clarified by Turner and his asso-
ciates (27). Although their work, carefully controlled, indicated that the differ-
ent results produced were due to substantial biologic differences between the
three spirochetes studied, we are not any nearer to the solution of the question
whether the syphiloid diseases, yaws, bejel, pinta, etc., are syndromes of the same
disease or are independent processes (Hudson (10)). In addition, theproblem
of immunity and allergy in syphilis is in need of reevaluation. In a recent review,
IJrbach and 1 (28) pointed out that much of the information on immunity is
based on experiments in \vhich cure was attained by the use of arsenicals. In
accordance with Worms' (29) ideas, unless the lymph node transfers made to
determine cure were performed at least a year after treatment, residual arsenical
in the organism may really only have suppressed the infection. Since penicillin
is rapidly eliminated and is presumed to be curative in animals this points the
way for future study.
LABORATORY PROBLEM5 IN SYPHILI5 DIAGNOSI5
In the laboratory aspects of the diagnosis of syphilis there remain a variety of
unsolved problems. There is no really satisfactory stain for Spiroehaeta pallida.
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This is exemplified by the multitude of methods of staining spirochetes recom-
mended by a host of investigators. Even the darkfield examination presents
innumerable problems and, to be sure, is of limited value at the time the desired
information is most useful. Clinicians long for a simple method of bacteriological
character which will enable them at the earliest possible moment to establish with
certainty a positive diagnosis of syphilis.
When the serologic tests for the diagnosis of syphilis were introduced by Was-
sermann, Neisser and Bruck, their specificity was accepted by the medical pro-
fession with implicit faith. Soon, however, it was found that falsely negative
reactions in syphilitics, as well as falsely positive reactions, were repeatedly
reported with all tests, not only in many nonsyphilitic diseases of human beings,
but in presumably normal nonsyphilitic persons as well. In spite of stepping up
sensitivity and specificity, and the introduction of new tests, verification proce-
dures, special antigens such as the spirochetal antigen and numerous other
devices of a combined clinical and laboratory nature, we are as far from a satis-
factory solution of this serologic problem as was the case fifteen or twenty years
ago. In fact, the recognition of the many factors involved in interpretation of a
serologic reaction has resulted in a somewhat lessened confidence in the tests and
a great deal of confusion in the minds of the practitioners. As Stokes (30)has
aptly stated, "This new question of how often a positive means syphilis; of how
to identify the positives that do not; in what diseases and with what frequency
non-specific or nonsyphilitic positives are obtained, suddenly rises to disturb the
diagnostic peace." In 1945 I made a survey (31) of the recent literature on the
subject of biologic false positive reactions to the tests for syphilis. Among the
more than three hundred references cited, I was able to gather little more than a
mere statement of the reported incidence of false positive reactions in many dis-
ease processes, plus a lot of conjectures about the possible cause of the reactions
and a rather feeble program for handling such cases in practice. Although much
effort has recently been directed toward this problem from various angles, there
remains much of a productive nature which further study will uncover.
Not oniy do we not have a simple, reliable, easily performed test for syphilis
which will always diagnose syphilis at the earliest possible moment when it is
present, and fail to give a positive reaction when it is absent, but we lack a test
which is able, even if it gives a positive reaction, to indicate whether the syphilis
is active or actually quiescent, infectious or noninfectious. No real knowledge
is as yet available concerning the relationship of blood factors to the serologic
outcome although work is in progress in this field. There is no definitive infor-
mation as to the effect of external factors on the serologic result. We have no
really standardized quantitative procedure. We know practically nothing about
reagin or even the mechanism of our present tests, just to mention a few of the
uncertainties which might be made a field for wider study. Although it may be
argued that competent serologists have tried and failed to solve these problems,
this argument against a try by dermato-syphilologists is no more valid than that
syphilologists have no right to exist as such since many fundamental discoveries
in syphilology have been made by men other than syphilologists.
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SOME PROBLEMS OF CLINICAL SYPHILOLOGY
The need for better appreciation and reevaluation of the finer points of clinical
diagnosis of syphilis is emphasized by the lessened reliance one may place on
laboratory tests. Some authorities even state that after long study it is practi-
cally impossible to identify Spirochaeta pallida with certainty. The great pro-
pensity previously mentioned for false serologic results with today's best tech-
nics, casts great doubt on the infallibility of the blood tests in diagnosis. Histo-
pathology, too, is not a final arbiter in diagnosis. In a sense, then, we must revert
to a great extent to the days of the old clinical masters and differentiate by careful
attention to clinical signs and employment of the multiple diagnostic approach of
Stokes (32), the various dermatoses which might be mistaken for syphilis and vie e
versa. It is not desirable or safe to assume the syphilitic character of a lesion
and because treatment (penicillin) is so harmless, to apply it on "suspicion."
Furthermore, the situation of dermatologic training without full grounding in
syphilology is aptly expressed by a British reviewer (33) of "MeKenna's Aids to
Dermatology," as follows: "Syphilis is now entirely omitted, which in a book on
dermatology rather suggests the tragedy of Hamlet with the character of the
Prince of Denmark left out." This need for exact knowledge of the manifesta-
tions of syphilis opens a wide field for careful study of the nature of the disease
and the discovery of exact means for clinical differentiation.
Although the dermatologist is essentially a clinician and his contribution to
the sohltion of the majority of the laboratory problems in syphilology is neces-
sarily limited, he can continue to contribute enormously to the study of many
clinical questions. In addition, because of his clinical background, the derma-
tologist can act as a control to keep the laboratory workers in line. He may
thus stimulate further work, evaluate and apply the results of the laboratory to
our field. For example, the recognition of the problem of nonspecific reactions
to the blood tests for syphilis is essentially the outcome of clinical studies in
which the serologic results were not in agreement with the clinical findings.
Likewise, the occurrence of an unusual clinical phenomenon or sequence in the
course of syphilis, e.g., treatment resistance, may afford the laboratory man un-
limited possibilities for study. Unless the dermatologist, who is most competent
to observe these clinical problems, takes an interest in syphilology, progress in
laboratory syphilology will lag or he forgotten.
Some of the unsolved problems of clinical syphilis were discussed in 1939 by
Moore (34A). The four problems he considered of paramount interest are still
enigmas today:
(a) The mode of infection, both in acquired and congenital syphilis.
(b) The localization of syphilitic lesions.
(c) The course of the syphilitic infection as modified by human constitution
and other factors.
(d) The importance of syphilis as a cause of death.
Thus, we know little about the mechanism of asymptomatie infection. In
congenital syphilis, we have little unequivocal evidence as to when and why the
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fetus is infected. (34B, 35). The question of third generation syphilis, in spite
of numerous reports (36) is still a matter of theory. Although we complacently
accept the fact that syphilis has a special affinity for certain tissues, notably the
skin, cardiovascular and nervous systems among others, we have no adequate
explanation for this. Nor, on the other hand, have we worked out the mechanism
or reason for spontaneous cure, not only in animals, but in man. The events
taking place and their modus operandi in latency are still a matter of surmise.
To this group of problems must be added that of relapse, reinfection and super-
infection.
Relapse, Reinfection and Superinfection
The problem of differentiation of relapse, reinfection and superinfection,
closely bound up with immunity and cure in syphilis, has taken on a renewed
importance with the reintroduction of intensive therapy. To date the situation
is far from clarified. For example, cases of reinfection which were infrequent
during the prearsphenamine era became much fore numerous shortly after the
introduction of the arsenicals into syphilotherapy. Soon, however, a reaction
tending toward more critical consideration of criteria of reinfection set in, so that
by 1931 Stokes, Schoch, and Ireland (37) rated reinfection as "a comparatively
rare event in the course of syphilis today." Since 1931 the literature is replete
with suggestions as to the uncertainty of what is meant by reinfection, so that
cases of so-called reinfection are reported as "suspected reinfections," "probable
reinfections," "apparent reinfections," "questionable reinfections," "presum-
able reinfections." Intensive therapy and especially, penicillin treatment, are
presumed to cure syphilis so rapidly that the host has no opportunity to de-
velop immunity. Therefore, reinfections are said to be frequent after this type
of treatment. Although animal studies permit precise control of certain factors
which may affect the development of immunity in experimental syphilis (time
factor, quality (virulence) and quantity of inoculum, the methods and the sites
of the first and the superinoculations, and the reaction of the animal to the first
inoculation [Worms (29)]) the results of these studies cannot be directly applied
to man. They do, however, serve to indicate certain trends which may be the
modus operandi of human reinfection. Clinical studies of reinfection in man, in
spite of the best efforts of competent observers, yield only inferential evidence
for the existence of the possibility of a second infection with syphilis. Deliber-
ate attempts to reinoculate syphilitics with spirochetes have yielded some so-
called superinfections but reinoculation of cured syphilitics has rarely been
successful [Beerman (38)]. Since we have no absolute criteria of biologic cure
nor adequate means to identify asymptomatic infections in man, it is possible
that reinfection may take place on a scale larger than hitherto suspected. It
is hardly likely that any amount of discussion of the results of the experiments
of the past, regardless of their value, will lead to a definitive opinion as to the
possibility of superinfection or reinfection for the individual. If the same data
reviewed by two such competent authorities as Chesney (39) and Truffi (40)
are given such diverse interpretations, it is not possible at this time to reconcile
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the two viewpoints except to construct an experiment on man which will yield
unequivocal results. To date, no one has had the foresight, knowledge or op-
portunity to outline such a study.
TREkTMENT PROBLEM5
It is hardly necessary to elaborate the present status of the treatmen of syphi-
lis to you. With the advent of penicillin therapy all seemed settled. But now
more than ever are we aware of the real gaps in our knowledge of the usefulness
of treatment and the proper modes of therapy. To name just a few: The mech-
anism of action and pharmacologic behavior and synthesis of the penicillins; a
suitable ambulatory method for penicillin administration; penicillin resistance;
the effect of the drugs on infection with Spiroehaeta pallida in the experimental
animal; time-dose relationship in man and the clinical effectiveness of the penicil-
lins in various types of syphilis. Since this group of problems appears to he the
chief field of current syphilis research, little more need be said than that the
dermatologist should assume a more prominent role in this endeavor.
I have in a somewhat sketchy, rambling fashion, indicated a few of the out-
standing problems in today's syphilology. I believe that the dermatologist is
legitimately charged with the obligation of attempting their solution, and that
the rewards of such efforts to the dermatologist will be more than satisfactory.
If he fails to solve any considerable portion of these questions he may take com-
fort in Neisser's (8) conviction that: "Human indolence and stupidity will ar-
range that syphilis will never die out but will remain always a dangerous disease,
but we know that new and wonderful weapons have been placed in our hands to
combat it. Let us practical physicians express our admiration and gratitude to
those men who created scientific foundations for these therapeutic triumphs:
Schaudinn, Hoffmann, Metehinikoff, Roux, Wassermann, Bruek and Paul Ehr-
lieh." To this list I hope the future historian of syphilology will add some of
your names.
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